MARKET

MYGN

MYGN

Myriad Genetics
NASDAQ
5.12
+0.02
+0.39%
After Hours: 5.12 0 0.00% 16:10 02/06 EST
OPEN
5.12
PREV CLOSE
5.10
HIGH
5.28
LOW
5.01
VOLUME
976.92K
TURNOVER
--
52 WEEK HIGH
15.47
52 WEEK LOW
3.760
MARKET CAP
477.25M
P/E (TTM)
-1.1808
1D
5D
1M
3M
1Y
5Y
1D
Does Myriad Genetics (NASDAQ:MYGN) Have A Healthy Balance Sheet?
Simply Wall St · 3d ago
Myriad Genetics management to meet with BTIG
TipRanks · 4d ago
Weekly Report: what happened at MYGN last week (0126-0130)?
Weekly Report · 5d ago
Myriad Genetics Unveils Commercialization Roadmap For Precise MRD Assay
NASDAQ · 01/27 17:21
Myriad Genetics to Launch Precise MRD Test for Breast Cancer in March 2026
Reuters · 01/27 14:46
Myriad Genetics advances MRD commercialization timeline
TipRanks · 01/27 13:55
Myriad Genetics Unveils 2026 Commercial Launch Of Precise MRD Assay, Highlighting Ultrasensitive ctDNA Detection Across Multiple Cancer Types
Benzinga · 01/27 13:51
Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
Barchart · 01/27 07:50
More
About MYGN
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health, and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test, which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, Foresight, Prequel, Precis Tumor, Precise Liquid, SneakPeek and GeneSight, among others.

Webull offers Myriad Genetics Inc stock information, including NASDAQ: MYGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MYGN stock methods without spending real money on the virtual paper trading platform.